These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25976605)

  • 1. The Genetic Basis of Coronary Artery Disease and Atrial Fibrillation: A Search for Disease Mechanisms and Therapeutic Targets.
    Neelankavil J; Rau CD; Wang Y
    J Cardiothorac Vasc Anesth; 2015 Oct; 29(5):1328-32. PubMed ID: 25976605
    [No Abstract]   [Full Text] [Related]  

  • 2. Polygenic Risk Scores in Coronary Artery Disease and Atrial Fibrillation.
    Gladding PA; Legget M; Fatkin D; Larsen P; Doughty R
    Heart Lung Circ; 2020 Apr; 29(4):634-640. PubMed ID: 31974023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary artery embolization after successful surgical ablation of atrial fibrillation.
    Wang LW; Omari A; Muller DW; Jacobs NH; Subbiah RN
    Circulation; 2013 Feb; 127(8):960-1. PubMed ID: 23439448
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial commentary: Clarifying the association between atrial fibrillation and coronary artery disease.
    Dixit S
    Trends Cardiovasc Med; 2024 Feb; 34(2):99-100. PubMed ID: 36403870
    [No Abstract]   [Full Text] [Related]  

  • 5. [Genetic testing in polygenic diseases : Atrial fibrillation, arterial hypertension and coronary artery disease].
    Trenkwalder T; Kessler T; Schunkert H
    Herz; 2017 Aug; 42(5):440-448. PubMed ID: 28536780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weighted gene coexpression network analysis of human left atrial tissue identifies gene modules associated with atrial fibrillation.
    Tan N; Chung MK; Smith JD; Hsu J; Serre D; Newton DW; Castel L; Soltesz E; Pettersson G; Gillinov AM; Van Wagoner DR; Barnard J
    Circ Cardiovasc Genet; 2013 Aug; 6(4):362-71. PubMed ID: 23863953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the management of intermediate coronary artery disease in patients with atrial fibrillation compared to sinus rhythm.
    Pintea Bentea G; Berdaoui B; Samyn S; Morissens M; van de Borne P; Castro Rodriguez J
    Coron Artery Dis; 2024 Mar; 35(2):156-159. PubMed ID: 38088794
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetics of atrial fibrillation: an update.
    Campbell HM; Wehrens XHT
    Curr Opin Cardiol; 2018 May; 33(3):304-310. PubMed ID: 29461262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of Atrial Fibrillation in 2020: GWAS, Genome Sequencing, Polygenic Risk, and Beyond.
    Roselli C; Rienstra M; Ellinor PT
    Circ Res; 2020 Jun; 127(1):21-33. PubMed ID: 32716721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing chronic disease management in the community (outpatient) setting (OCDM): an evidentiary framework.
    OHTAC OCDM Collaborative
    Ont Health Technol Assess Ser; 2013; 13(3):1-78. PubMed ID: 24143159
    [No Abstract]   [Full Text] [Related]  

  • 11. Genomic basis of atrial fibrillation.
    Bapat A; Anderson CD; Ellinor PT; Lubitz SA
    Heart; 2018 Feb; 104(3):201-206. PubMed ID: 28893835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetics of atrial fibrillation].
    Le Marec H; Probst V
    Ann Cardiol Angeiol (Paris); 2009 Dec; 58 Suppl 1():S70-2. PubMed ID: 20103189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple, dual, and single antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y; Kobayashi Y
    Cardiovasc Interv Ther; 2020 Jan; 35(1):44-51. PubMed ID: 31281936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of 15 novel risk loci for coronary artery disease and genetic risk of recurrent events, atrial fibrillation and heart failure.
    Verweij N; Eppinga RN; Hagemeijer Y; van der Harst P
    Sci Rep; 2017 Jun; 7(1):2761. PubMed ID: 28584231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial fibrillation incidence after coronary artery bypass graft surgery and percutaneous coronary intervention: the prospective AFAF cohort study.
    Wickbom A; Fengsrud E; Alfredsson J; Engdahl J; Kalm T; Ahlsson A
    Scand Cardiovasc J; 2024 Dec; 58(1):2347297. PubMed ID: 38695238
    [No Abstract]   [Full Text] [Related]  

  • 16. Genome Editing and Atrial Fibrillation.
    Spartalis M
    Adv Exp Med Biol; 2023; 1396():129-137. PubMed ID: 36454464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continued expansion of the Heart Team concept.
    Passeri JJ; Melnitchouk S; Palacios IF; Sundt TM
    Future Cardiol; 2015 Mar; 11(2):219-28. PubMed ID: 25760880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of atrial fibrillation in patients with stable coronary artery disease: a systematic review and meta-analysis of adjusted observational studies.
    Saglietto A; Varbella V; Ballatore A; Xhakupi H; Ferrari GM; Anselmino M
    Rev Cardiovasc Med; 2021 Jun; 22(2):439-444. PubMed ID: 34258910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic aspects of atrial fibrillation in coronary artery disease patients].
    Tseluĭko VI; Iakovleva LN; Vashakidze ZS
    Georgian Med News; 2013 Oct; (223):35-40. PubMed ID: 24214591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance of a High Polygenic Score Among Relatives: Implications for Genetic Counseling and Cascade Screening.
    Reid NJ; Brockman DG; Elisabeth Leonard C; Pelletier R; Khera AV
    Circ Genom Precis Med; 2021 Apr; 14(2):e003262. PubMed ID: 33794649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.